Therefore, additional studies of the role of SHIP2 in CRC are warranted, as this could provide alternative ways to approach inhibition of the PI3K/AKT axis as a means of treatment for a subset of colon cancer tumors. Here, INPPL1 is linked to colorectal carcinoma.